Anatara Lifesciences reaches milestone in Phase 2 IBS treatment study

By Small Caps / April 15, 2024 / www.youtube.com / Article Link


Anatara Lifesciences (ASX: ANR) executive chair Dr David Brookes joins Small Caps to discuss the progress of the company's ...

Recent News

US tariff decision expected to be major copper catalyst

July 07, 2026 / www.canadianminingreport.com

Gold stocks rebound from near lows

July 07, 2026 / www.canadianminingreport.com

Gold stocks decline as metal price drops

June 29, 2026 / www.canadianminingreport.com

Tech takes a hit on South Korea semiconductor decline

June 29, 2026 / www.canadianminingreport.com

Gold stocks rise even as metal drops for second week

June 22, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok